# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Mumtaz Mahal (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-RE006-SYN
- Date: 2026-01-06
- Fictional facility: St. Posthumous Health Center
- Fictional author: Farzana Qureshi-Lindholm, MD
- Calendar frame: modern shifted

## Reason for visit

First prenatal visit at 13 weeks in a fourteenth pregnancy: dating and nuchal translucency scan, prenatal tests, and a high-risk plan. **S**

## Historical basis

- She was born Arjumand Banu Begum in Agra in April 1593; an encyclopedia, citing a seventeenth-century court history, gives 27 April 1593. **D**
- Her father, Abu'l-Hasan Asaf Khan, was a Persian noble; his sister was the Empress Nur Jahan, wife of the emperor Jahangir. Her mother's family came from Qazvin in Persia. **D**
- She was betrothed to Prince Khurram, later the emperor Shah Jahan, in 1607, and married him on 10 May 1612; he gave her the title Mumtaz Mahal, rendered as 'Chosen One of the Palace' or 'the Exalted One of the Palace'. **D**
- She was a Shi'a Muslim. **D**
- Despite her frequent pregnancies, she travelled with her husband's entourage on his military campaigns. **D**
- Her first thirteen children were born between 1613 and 1630: Hur-ul-Nisa (1613), Jahanara (1614), Dara Shikoh (1615), Shah Shuja (1616), Roshanara (1617), Aurangzeb (1618), Izad Bakhsh (1619), Surayya Banu (1621), a son who died soon after birth (1622), Murad Bakhsh (1624), Lutf Allah (1626), Daulat Afza (1628), and Husn Ara (1630). **D**
- Six of her children died in infancy or early childhood before 1631: Hur-ul-Nisa at three and Surayya Banu at seven, both of smallpox; Izad Bakhsh in infancy; a son soon after birth in 1622; Lutf Allah at about eighteen months; and Daulat Afza in infancy. **D**
- Her thirteenth child, Husn Ara, was born on 23 April 1630. **D**
- In the year 1040 AH (from August 1630) the emperor was in the Deccan with the court at Burhanpur, during a severe famine in the Deccan and Gujarat, when he ordered soup kitchens and weekly alms for as long as he remained at Burhanpur. **D**

6 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- Pregnant again soon after her last baby; tired and breathless on stairs, and unsure how far along she is. **S**
- She has lost six children and wants to do everything possible for this baby and to be well enough for the children she has. **S**
- Her family may travel again during the pregnancy and she wants to know when and how she can travel safely. **S**

## Strengths and supports

- Supports: a large household, her eldest daughter, and a close woman friend who travels with her **S**

## Medications and allergies

- Folic acid 0.4 mg oral tablet, one tablet by mouth daily **S**
- Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other day **S**
- Aspirin 81 mg delayed-release tablet, one tablet by mouth at bedtime **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- 1613 to 1630: Thirteen births between 1613 and 1630, the last in April 1630, while travelling with the court **D** (CLM-0006, CLM-0005)

## Procedures and immunizations

- 2026-01-06 to 2026-01-06: First-trimester ultrasound for dating and nuchal translucency: single live intrauterine fetus, crown-rump length 72 mm (13 weeks 2 days), nuchal translucency 1.7 mm, nasal bone present; placenta posterior; no structural abnormality seen **S**
- 2026-01-06: Influenza vaccine, 2025-2026 season, given in pregnancy **S**

## Family history

- natural daughter: Eldest daughter died of smallpox in 1616, aged three **D** (CLM-0007)
- natural son: A son died in infancy in 1621; cause not recorded in the cited source **D** (CLM-0007)
- natural son: A son died soon after birth in 1622; cause not recorded in the cited source **D** (CLM-0007)
- natural daughter: A daughter died of smallpox in 1628, aged seven **D** (CLM-0007)
- natural son: A son died in 1628 at about eighteen months; cause not recorded in the cited source **D** (CLM-0007)
- natural son: A son died in infancy in 1629; cause not recorded in the cited source **D** (CLM-0007)

## Measurements

Hemoglobin: 10.1 g/dL (low); MCV: 76 fL (low); White blood cells: 8.6 10*3/uL; Platelets: 245 10*3/uL; Ferritin: 9 ng/mL (low); Hemoglobin A1c: 5.4%; Crown-rump length: 72 mm; Nuchal translucency: 1.7 mm; EPDS: 8. All results are synthetic.

BP 104/64 mmHg; pulse 84 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 99% on room air; weight 58.6 kg; BMI 23.8 kg/m². All vital signs are synthetic.

## Examination

Mental status: Composed, warm, and articulate; mood "tired but glad"; anxious about the pregnancy because of the children she has lost; no thoughts of self-harm; EPDS 8 with item 10 scored 0. Functional status: Independent; manages a large household; tired by afternoon and breathless on stairs since the pregnancy began. Physical examination is intentionally limited. **S**

## Assessment

1. Fourteenth pregnancy at 37 (gravida 14, para 13), single live intrauterine pregnancy dated by ultrasound at 13 weeks 2 days; estimated due date July 12; status draft. **S**
2. Grand multiparity: thirteen previous vaginal births, no cesarean or other uterine surgery; seven living children; status draft. **S**
3. Short interpregnancy interval: conception about five and a half months after her last birth; status draft. **S**
4. Iron deficiency anemia in pregnancy: hemoglobin 10.1 g/dL, MCV 76 fL, ferritin 9 ng/mL; status draft. **S**

## Plan

- First prenatal visit: dating and nuchal translucency scan; blood count, ferritin, blood group and antibody screen, rubella immunity, hepatitis B surface antigen, HIV, syphilis, and hepatitis C tests; urine culture for asymptomatic bacteriuria; hemoglobin electrophoresis for microcytosis; hemoglobin A1c as an early diabetes screen; influenza vaccine; folic acid. Guideline: Pregnancy at Age 35 Years or Older: ACOG Obstetric Care Consensus No. 11 (2022); USPSTF A and B Recommendations (2026); Guidelines for Vaccinating Pregnant Persons (2026) **S**
- Aneuploidy screening offered, with diagnostic testing available: cell-free DNA and the nuchal translucency measurement today, or chorionic villus sampling or amniocentesis; she chose cell-free DNA. Guideline: Pregnancy at Age 35 Years or Older: ACOG Obstetric Care Consensus No. 11 (2022); Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226 (2020) **S**
- Maternal-fetal medicine consultation for a fourteenth pregnancy at 37 with a short interpregnancy interval and anemia: surveillance, anemia treatment, placental assessment, delivery timing and place, and postpartum hemorrhage planning. Guideline: Pregnancy at Age 35 Years or Older: ACOG Obstetric Care Consensus No. 11 (2022); Practice Bulletin No. 183: Postpartum Hemorrhage (2017) **S**
- Iron deficiency anemia: ferrous sulfate 325 mg every other day; repeat blood count and ferritin in four weeks, with intravenous iron in the second trimester if she cannot tolerate oral iron or the hemoglobin does not rise; aim for hemoglobin of 11 g/dL or more before delivery. Guideline: Anemia in Pregnancy: ACOG Practice Bulletin, Number 233 (2021) **S**
- Preeclampsia prevention: aspirin 81 mg at bedtime from 13 weeks until delivery for two moderate risk factors (age 35 or older and a previous adverse pregnancy outcome); blood pressure and urine protein at every visit. Guideline: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication (2021) **S**
- Detailed anatomy scan at 20 to 22 weeks with placental location; if the placenta is low-lying or covers the cervix, a repeat scan at 32 weeks and assessment for placenta accreta spectrum. Guideline: Pregnancy at Age 35 Years or Older: ACOG Obstetric Care Consensus No. 11 (2022); Obstetric Care Consensus No. 7: Placenta Accreta Spectrum (2018) **S**
- Gestational diabetes: hemoglobin A1c today because she is of South Asian heritage with a BMI of 23 or more; one-hour glucose challenge at 24 to 28 weeks. Guideline: ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus (2018) **S**
- Travel: travel is reasonable until about 36 weeks if the pregnancy stays uncomplicated; on long journeys walk every one to two hours, drink plenty, and wear compression stockings; carry her prenatal record; find maternity care where she stays; stay near the delivery hospital from 36 weeks. Guideline: ACOG Committee Opinion No. 746: Air Travel During Pregnancy (2018) **S**
- Postpartum hemorrhage risk assessment at intake and again in the third trimester and on admission for birth (grand multiparity and anemia raise her risk); delivery planned in a hospital with a blood bank, anesthesia, and an operating theatre. Guideline: Practice Bulletin No. 183: Postpartum Hemorrhage (2017); WHO recommendations for the prevention and treatment of postpartum haemorrhage (2012) **S**
- Mood: EPDS in each trimester, with support for the grief of having lost several children. Guideline: Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum (Clinical Practice Guideline No. 4) (2023) **S**

## Guideline basis

- Pregnancy at Age 35 Years or Older: ACOG Obstetric Care Consensus No. 11 (2022), American College of Obstetricians and Gynecologists and Society for Maternal-Fetal Medicine (Obstetrics & Gynecology)
- Practice Bulletin No. 183: Postpartum Hemorrhage (2017), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- WHO recommendations for the prevention and treatment of postpartum haemorrhage (2012), World Health Organization
- Anemia in Pregnancy: ACOG Practice Bulletin, Number 233 (2021), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226 (2020), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication (2021), U.S. Preventive Services Task Force
- ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus (2018), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- Obstetric Care Consensus No. 7: Placenta Accreta Spectrum (2018), American College of Obstetricians and Gynecologists and Society for Maternal-Fetal Medicine (Obstetrics & Gynecology)
- ACOG Committee Opinion No. 746: Air Travel During Pregnancy (2018), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum (Clinical Practice Guideline No. 4) (2023), American College of Obstetricians and Gynecologists
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Guidelines for Vaccinating Pregnant Persons (2026), Centers for Disease Control and Prevention
